Selection for transcatheter versus surgical aortic valve replacement and mid-term survival: results of the AUTHEARTVISIT study
European Journal of Cardio-Thoracic Surgery · 01.07.2024 · 66 (1)
DOI: 10.1093/ejcts/ezae214 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift European Journal of Cardio-Thoracic Surgery, online erschienen am 14.06.2024. Verfasst von Johann Auer und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine I with Cardiology and Intensive Care, St Josef Hospital Braunau, Braunau am Inn, Austria. Hauptthemen laut MEDLINE: Transcatheter Aortic Valve Replacement, Aortic Valve Stenosis, Heart Valve Prosthesis Implantation, Aortic Valve. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
OBJECTIVES Limited data are available from randomized trials comparing outcomes between transcatheter aortic valve replacement (TAVR) and surgery in patients with different risks and with follow-up of at least 4 years or longer. In this large, population-based cohort study, long-term mortality and morbidity were investigated in patients undergoing aortic valve replacement (AVR) for severe aortic stenosis using a surgically implanted bioprosthesis (surgical/biological aortic valve replacement; sB-AVR) or TAVR. METHODS Individual data from the Austrian Insurance Funds from 2010 through 2020 were analysed. The primary outcome was all-cause mortality, assessed in the overall and propensity score-matched populations. Secondary outcomes included reoperation and cardiovascular events. RESULTS From January 2010 through December 2020, a total of 18 882 patients underwent sB-AVR (n = 11 749; 62.2%) or TAVR (n = 7133; 37.8%); median follow-up was 5.8 (95% CI 5.7–5.9) years (maximum 12.3 years). The risk of all-cause mortality was higher with TAVR compared with sB-AVR: hazard ratio 1.552, 95% confidence interval (CI) 1.469–1.640, P < 0.001; propensity score-matched hazard ratio 1.510, 1.403–1.625, P < 0.001. Estimated median survival was 8.8 years (95% CI 8.6–9.1) with sB-AVR versus 5 years (4.9–5.2) with TAVR. Estimated 5-year survival probability was 0.664 (0.664–0.686) with sB-AVR versus 0.409 (0.378–0.444) with TAVR overall, and 0.690 (0.674–0.707) and 0.560 (0.540–0.582), respectively, with propensity score matching. Separate subgroup analyses for patients aged 65–75 years and >75 years indicated a significant survival benefit in patients selected for sB-AVR in both groups. Other predictors of mortality were age, sex, previous heart failure, diabetes and chronic kidney disease. CONCLUSIONS In this retrospective national population-based study, selection for TAVR was significantly associated with higher all-cause mortality compared with sB-AVR in patients ≥65 years with severe, symptomatic aortic stenosis in the >2-year follow-up.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine I with Cardiology and Intensive Care, St Josef Hospital Braunau, Braunau am Inn, Austria.
- Center for Medical Data Science, Medical University of Vienna, Vienna, Austria.
- Austrian Social Health Insurance Fund, Eisenstadt, Austria.
- Clinic of Thoracic Surgery, Medical University of Vienna, Vienna, Austria.
- Laboratory for Cardiac and Thoracic Diagnosis, Regeneration and Applied Immunology, Vienna, Austria.
- Department of Oral and Maxillofacial Surgery, Medical University of Vienna, Vienna, Austria.
ORCID-Profile: Denise Traxler
Zitieren
APA
Auer, J., Krotka, P., Reichardt, B., Traxler, D., Wendt, R., Mildner, M., Ankersmit, H. J., & Graf, A. (2024). Selection for transcatheter versus surgical aortic valve replacement and mid-term survival: results of the AUTHEARTVISIT study. European Journal of Cardio-Thoracic Surgery, 66(1). https://doi.org/10.1093/ejcts/ezae214
Vancouver
Auer J, Krotka P, Reichardt B, Traxler D, Wendt R, Mildner M, et al. Selection for transcatheter versus surgical aortic valve replacement and mid-term survival: results of the AUTHEARTVISIT study. European Journal of Cardio-Thoracic Surgery. 2024;66(1). doi:10.1093/ejcts/ezae214
BibTeX
@article{Auer2024,
author = {Auer, Johann and Krotka, Pavla and Reichardt, Berthold and Traxler, Denise and Wendt, Ralph and Mildner, Michael and Ankersmit, Hendrik Jan and Graf, Alexandra},
title = {Selection for transcatheter versus surgical aortic valve replacement and mid-term survival: results of the AUTHEARTVISIT study},
journal = {European Journal of Cardio-Thoracic Surgery},
year = {2024},
volume = {66},
number = {1},
doi = {10.1093/ejcts/ezae214}
}
EUVIMED